Sep 04, 2020
Highfield Diagnostics COVID19 LFA Protocol
- 1Highfield Diagnostics, UK
- Highfield Diagnostics
Collection Citation: peijun he 2020. Highfield Diagnostics COVID19 LFA Protocol. protocols.io https://dx.doi.org/10.17504/protocols.io.bkszkwf6
License: This is an open access collection distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol in our laboratory and it is working
Created: September 04, 2020
Last Modified: September 04, 2020
Collection Integer ID: 41529
Disclaimer
DISCLAIMER – FOR INFORMATIONAL PURPOSES ONLY; USE AT YOUR OWN RISK
The protocol content here is for informational purposes only and does not constitute legal, medical, clinical, or safety advice, or otherwise; content added to protocols.io is not peer reviewed and may not have undergone a formal approval of any kind. Information presented in this protocol should not substitute for independent professional judgment, advice, diagnosis, or treatment. Any action you take or refrain from taking using or relying upon the information presented here is strictly at your own risk. You agree that neither the Company nor any of the authors, contributors, administrators, or anyone else associated with protocols.io, can be held responsible for your use of the information contained in or linked to this protocol or any of our Sites/Apps and Services.
Abstract
Highfield Diagnositc`s has developed a COVID-19 rapid diagnostic test (RDT), which is a lateral flow immunochromatographic assay (LFA), that detects nucleoproteinin nasal swab specimens.The test provides a simple colorimetric readout of results in less than 30 minutes (including sample preparation time) at a cost of <$5 per test, with no special reader or additional equipment. This scalable and accessible solution puts simple and frequent testing capacity, without the need for skilled personnel, into the hands of billions across the world.
Attachments
DISCLAIMER – FOR INFORMATIONAL PURPOSES ONLY; USE AT YOUR OWN RISK
The protocol content here is for informational purposes only and does not constitute legal, medical, clinical, or safety advice, or otherwise; content added to protocols.io is not peer reviewed and may not have undergone a formal approval of any kind. Information presented in this protocol should not substitute for independent professional judgment, advice, diagnosis, or treatment. Any action you take or refrain from taking using or relying upon the information presented here is strictly at your own risk. You agree that neither the Company nor any of the authors, contributors, administrators, or anyone else associated with protocols.io, can be held responsible for your use of the information contained in or linked to this protocol or any of our Sites/Apps and Services.
Attachments
